Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes Mellitus
Status:
Recruiting
Trial end date:
2026-02-28
Target enrollment:
Participant gender:
Summary
To evaluate the similarity of the efficacy and safety of semaglutide injection (HD1916) vs.
Ozempic® in patients with type 2 diabetes mellitus (T2DM) with poor blood glucose control
after metformin treatment.